Genetically Modified HPV Vaccine Increases Risk Of Developing Cervical Cancer

By On March 30, 2017

As of March 2012, the Vaccine Adverse Reporting System (VAERS) stated there were 25,548 adverse events and over 100 deaths reported as a direct result of the HPV vaccine.

That was five years ago. How many more cases have there been? How many more will there be in the years to come?

INCREASED Cancer Risk and Health Problems Due to HPV Vaccination

In the chart below, notice the increase in abnormal pap smears, cervical dysplasia, and cervical cancer AFTER injection with the Gardasil vaccine.

What’s even more concerning is that girls who have already been exposed to HPV have a 44.6% increased risk for precancerous lesions developing after inoculation with Gardasil.

Yes, you read that right!

The cervical cancer vaccine raises the risk of cervical cancer for anyone exposed to HPV before they were vaccinated.

Yet medical professionals have no plans to screen patients prior to vaccination.

A normal phenomenon in virology called “replacement” is when virus strains which have been removed are replaced by new ones.

Dr. Charlotte Haug, an immunologist and chief editor of The Journal of Norwegian Medicine, writes about concerns of increased cancer post vaccination. “Results from clinical trials are not encouraging. Vaccinated women show an increased number of precancerous lesions caused by strains of HPV other than HPV-16 and HPV-18. The results are not statistically significant, but if the trend is real – and further clinical trials should tell us in a few years – there is reason for serious concern.”

It’s recently been discovered that genetically modified HPV DNA, which was firmly attached to the aluminum adjuvant, was found in a 13-year-old girl who developed acute juvenile rheumatoid arthritis following her third Gardasil injection. The consequences of the presence of recombinant HPV DNA (a biohazard) could prove to be catastrophic.

Is the HPV Vaccination for Cervical Cancer Worth the Risk?

According to the FDA’s guidelines, the tolerance for serious adverse reactions should be narrow when injecting a healthy person with a vaccine with uncertain benefits. Yet, Gardasil is marketed widely to girls ages 9 to 12. With such a low death rate from cervical cancer the risk to those vaccinated should be minimal.

If a person has already been exposed to HPV, there’s absolutely no benefit from vaccination.

Most commonly, women do not develop cervical cancer until 35-45 years of age. By this time, most women are receiving annual pap tests which identify early stages of cancer.

The package insert states the vaccine has not been tested to see if it can cause cancer.

As the testing period for the vaccine was too short to evaluate any long-term benefits, manufactures of HPV vaccines have failed to present significant data that their product can prevent cervical cancer.

Invasive cervical cancer takes 20-40 years to develop from the time of HPV infection, so is it really worth all the young lives lost? Is there any benefit at all… for anyone?

The public has been duped.

While well-meaning parents were deceived into having their daughters vaccinated with an untested and uncertain drug, the pharmaceutical company raked in billions of dollars in profit, which then trickled down to the doctors and agencies who pushed the vaccines.

Please be sure to watch Episode 5 of The Truth About Vaccines: Considering the HPV and Hepatitis B Vaccines, SIDS and Shaken Baby Syndrome. Watch for free by clicking here.
(Begins April 16, 2017 at 9pm EST and airs for free for 24 hours)

The original article can be viewed in its entirety by clicking here.